Skip to content

Antibody therapies for lymphoma in children.

by on February 28, 2016

SourceCochrane Database Syst Rev. 2016 Jan 19;1:CD011181.

Follow this link for fulltext

Date of publication: January, 2016

Publication type: Systematic review

In a nutshell: This systematic review aims to assess the efficacy of antibody therapy for childhood lymphoma in terms of survival, response and relapse rates, compared with therapy not including antibody treatment and to assess quality of life and the occurrence of adverse effects caused by antibody therapy treatment in children compared with therapy not including antibody treatment.

Some important notes: In case you experience difficulty obtaining this article,  please ask your local health librarian to locate this for you.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: